{"url_path":"/sec/anip/8-k/2026-05-21/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000056-index.html","accession_number":"0001023024-26-000056","cik":"0001023024","ticker":"ANIP","issuer_name":"ANI PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000056-index.html","primary_entity_key":"0001023024","primary_entity_name":"ANI PHARMACEUTICALS INC"},"word_count":559,"has_tables":true,"body_markdown":"Item 5.07Submission of Matters to a Vote of Security Holders\n\nAt the Annual Meeting, the following matters were submitted to a vote of stockholders:\n\n1.The election of seven (7) director nominees, each to serve until the Company’s 2027 Annual Meeting of Stockholders and thereafter until their successors are duly elected and qualified, or until their earlier death, resignation or removal;\n\n2.The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026;\n\n3.The approval of the compensation of the Company’s named executive officers, on an advisory basis;\n\n4.The approval of the frequency of future advisory votes to approve the compensation of the Company’s named executive officers, on an advisory basis; and\n\n5.The approval of the Amended 2022 Stock Plan.\n\nAt the close of business on March 23, 2026, the record date for the determination of stockholders entitled to vote at the Annual Meeting, there were 22,750,198 shares of the Company’s Common Stock outstanding and entitled to vote at the Annual Meeting and 10,864 shares of the Company’s Class C Special Stock outstanding and entitled to vote at the Annual Meeting. Accordingly, there were an aggregate of 22,761,062 votes entitled to be cast at the Annual Meeting, of which an aggregate of 16,926,047 were present virtually or represented by proxy, constituting a quorum.\n\nAt the Annual Meeting, (i) each of the seven (7) director nominees were elected, (ii) the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified, (iii) the compensation of the Company’s named executive officers was approved on an advisory basis, (iv) the stockholders voted, on an advisory basis, that future advisory votes to approve the compensation of the Company’s named executive officers be held every one year, and (v) the Amended 2022 Stock Plan was approved.\n\nProposal No. 1 — Election of the Directors\n\nThe vote with respect to the election of each of the director nominees was as follows:\n\nNomineesForAgainstAbstainBroker Non-Votes\n\nThomas Haughey14,732,894159,7653,1662,030,222\n\nNikhil Lalwani14,873,79615,1986,8312,030,222\n\nMatthew J. Leonard, R.Ph. 14,743,471149,0953,2592,030,222\n\nAntonio R. Pera14,542,012350,6493,1642,030,222\n\nMuthusamy Shanmugam14,849,62442,2533,9482,030,222\n\nRenee P. Tannenbaum, Pharm.D.14,063,620829,5662,6392,030,222\n\nJeanne A. Thoma14,565,758327,3932,6742,030,222\n\nProposal No. 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm\n\nThe vote with respect to the ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was as follows:\n\nForAgainstAbstain\n\n16,874,1037,33344,611\n\nProposal No. 3 — Approval of the Say-on-Pay Proposal\n\nThe vote with respect to the approval of the compensation of the Company’s named executive officers, on an advisory basis, was as follows:\n\nForAgainstAbstainBroker Non-Votes\n\n13,819,9881,058,46017,3772,030,222\n\nProposal No. 4 — Approval of Frequency of Say-on-Pay Proposal\n\nThe vote with respect to the approval of the frequency of future advisory votes on the compensation of the Company’s named executive officers was as follows:\n\nONE YEARTWO YEARS THREE YEARS AbstainBroker Non-Votes\n\n14,412,2994,947467,23611,3432,030,222\n\nAs a result of the foregoing vote, the Board of Directors of the Company has determined that the Company will hold an advisory vote on the compensation of the Company’s named executive officers every one year.\n\nProposal No. 5 — Approval of the Amended 2022 Stock Plan\n\nThe vote with respect to the approval of the Amended 2022 Stock Plan was as follows:\n\nForAgainstAbstainBroker Non-Votes\n\n13,806,0501,080,3879,3882,030,222"}